Hero Curved Left No Overlay
Relievant Announces Completion of $58M Series E Financing to Support US Commercialization
Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic low back pain (CLBP), announced today the completion of a $58 million equity financing. The round was led by Endeavour Vision and included participation...
Relievant Appoints Christopher Geyen Chief Financial Officer
Relievant Medsystems, a privately held medical device company that has developed the Intracept® Procedure, a minimally invasive and clinically proven approach for the treatment of chronic low back pain, announced today the appointment of Christopher Geyen as Chief...
Relievant Announces Publication of Positive Outcomes in 12-Month SMART Sham RCT
Relievant Medsystems, a privately held medical device company that developed the Intracept® Procedure, a minimally invasive and clinically proven approach for the treatment of chronic low back pain (CLBP), announced today the publication of the pivotal SMART Trial...
Relievant Medsystems Announces First Patient Enrollment in the INTRACEPT Clinical Study
Relievant Medsystems, a privately held medical device company that has developed the Intracept® Procedure, a minimally invasive and clinically proven approach for the treatment of chronic low back pain, announced today the enrollment of the first patient in the...
Relievant Medsystems Names Ray M. Baker, M.D. as Chief Medical Officer
Relievant Medsystems, a privately held medical device company that has developed the Intracept® Procedure, a minimally invasive and clinically proven approach for the treatment of chronic low back pain, today announced the appointment of Ray M. Baker, M.D., as Chief...
Relievant Medsystems Names Kevin Hykes Chief Executive Officer
Relievant Medsystems, a privately held medical device company that has developed the Intracept® Procedure, a minimally invasive and clinically proven approach for the treatment of chronic low back pain, announced today that Kevin Hykes has been appointed President and...
Relievant Medsystems, Inc. Secures $36 Million in Equity Financing for INTRACEPT® Clinical Development and Commercial Launch Preparation
INTRACEPT® Intraosseous Nerve Ablation System recently received FDA clearance to treat chronic low back pain (CLBP) based on results of landmark SMART clinical trial. CLBP affects millions of patients in the United States and around the world, and effective, safe and...
Relievant Medsystems, Inc. Receives FDA 510(k) Clearance for INTRACEPT® for the Relief of Chronic Low Back Pain
Relievant Medsystems, Inc., a privately held medical device company pioneering the therapy of nerve ablation within vertebral bodies for the treatment of chronic low back pain, announced today that it received U.S. Food and Drug Administration (FDA) 510(k) clearance...
Relievant MedSystems Begins SMART Trial for the Alleviation of Chronic Low Back Pain
Relievant MedSystems Inc. today announced the company has enrolled the first patient in its SMART trial to evaluate the Intracept® Basivertebral Nerve Ablation Procedure. The Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain...
Relievant Medsystems Appoints Alex M. DiNello as President and Chief Executive Officer
Relievant Medsystems, Inc., today announced the appointment of Alex DiNello to the position of president and chief executive officer and as a member of the company's board of directors. The Company recently received FDA approval of an Investigational Device Exemption...
Hero Curved Left Overlay
Hero Curved Center
That’s Living
Proof.
Hero Curved Right
Welcome to the proof
of Intracept
Hero Image Text
Mattis Parturient Vestibulum Risus Sit
Morbi leo risus, porta ac consectetur ac, vestibulum at eros.
Image Text
Duis mollis, est non commodo luctus, nisi erat porttitor ligula, eget lacinia odio sem nec elit. Curabitur blandit tempus porttitor. Fusce dapibus, tellus ac cursus commodo, tortor mauris.
Morbi leo risus, porta ac consectetur ac, vestibulum at eros.
Chart Text
Mattis Parturient Vestibulum Risus Sit
Key Findings:
Vulputate Pellentesque Lorem Adipiscing
Key Findings:
Vulputate Pellentesque Lorem Adipiscing
Video Text
Mattis Parturient Vestibulum Risus Sit
Duis mollis, est non commodo luctus, nisi erat porttitor ligula, eget lacinia odio sem nec elit. Curabitur blandit tempus porttitor. Fusce dapibus, tellus ac cursus commodo, tortor mauris.
3 Column Image
The Data Is Living Proof Too
Fewer Opiods
Maecenas sed diam eget risus varius blandit sit amet non magna. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus.
Fewer Opiods
Maecenas sed diam eget risus varius blandit sit amet non magna. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus.
Fewer Opiods
Maecenas sed diam eget risus varius blandit sit amet non magna. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus.
Curve Right Text
Mattis Parturient Vestibulum Risus Sit
Curve Left Text
Mattis Parturient Vestibulum Risus Sit
Curve Left Text Overlay
Icon Lists
Intracept Quick Facts
Parturient Aenean Ornare Lorem
Etiam Fringilla Ultricies Tristique Consectetur
Parturient Aenean Ornare Lorem
Etiam Fringilla Ultricies Tristique Consectetur
Parturient Aenean Ornare Lorem
Etiam Fringilla Ultricies Tristique Consectetur
Accordion Cards
How we’re living the proof.
Now in Effect: New Category | CPT Codes
Intracept Long Term Outcomes
New Patient Story
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
Indications (Global)
As with any surgical procedure, there are risks and considerations associated with the Intracept Procedure. See important safety information below.
Physicians: See Indications, Contraindications, and Risks
Indications for Use: The Intracept™ Intraosseous Nerve Ablation System is intended to be used in conjunction with radiofrequency (RF) generators for the ablation of basivertebral nerves of the L3 through S1 vertebrae for the relief of chronic low back pain of at least six months duration that has not responded to at least six months of conservative care, and is also accompanied by features consistent with Type 1 or Type 2 Modic changes on an MRI such as inflammation, edema, vertebral endplate changes, disruption and fissuring of the endplate, vascularized fibrous tissues within the adjacent marrow, hypointensive signals (Type 1 Modic change), and changes to the vertebral body marrow including replacement of normal bone marrow by fat, and hyperintensive signals (Type 2 Modic change). Contraindications - Use of the Intracept Intraosseous Nerve Ablation System is contraindicated in: Patients with severe cardiac or pulmonary compromise, patients with active implantable pulse generators (e.g. pacemakers, defibrillators), patients where the targeted ablation zone is < 10 mm away from a sensitive structure not intended to be ablated, including the vertebral foramen (spinal canal), patients with active systemic infection or local infection in the area to be treated, patients who are pregnant, and/or skeletally immature patients (generally ≤ 18 years of age). Refer to the Instructions for Use provided with the Intracept Procedure or www.relievant.com/intracept/ for potential adverse effects, warnings, and precautions prior to using this product.
Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.
Copyright © 2025 by Boston Scientific Corporation or its affiliates. All rights reserved.
Patients: See the Indications & Risks Involved
Contraindications include being pregnant, having weakened cardiac or pulmonary function, having an active implanted electronic medical device in the body (such as a pacemaker or defibrillator), being diagnosed with a systemic or local infection, or having an anatomy that could be damaged unintentionally while ablating the basivertebral nerve (based on your physicians’ clinical review). The Intracept Procedure is also contraindicated in patients who are skeletally immature – which generally means individuals under the age of 18 are not candidates. There are also certain risks and precautions regarding the procedure which you should be aware of before proceeding. Talk with your doctor about what indicates, and contraindicates, certain patients for the Intracept Procedure – as well as the risks and precautions for the procedure. For complete indications for use, contraindications, warnings, precautions, and side effects visit www.relievant.com/intracept/.
Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.
Copyright © 2025 by Boston Scientific Corporation or its affiliates. All rights reserved.
Accordion List
Physicians
Curabitur blandit tempus porttitor. Aenean eu leo quam. Pellentesque ornare sem lacinia quam venenatis vestibulum. Morbi leo risus, porta ac consectetur ac, vestibulum at eros.
Intracept Long Term Outcomes
Curabitur blandit tempus porttitor. Aenean eu leo quam. Pellentesque ornare sem lacinia quam venenatis vestibulum. Morbi leo risus, porta ac consectetur ac, vestibulum at eros.
New Patient Story
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
Carousel Doctor
What Physicians Are Saying About Intracept
Brian Durkin, DO
NY Health,
Port Jefferson Station, NY
“If I see people with Modic changes I say, 'that's probably where your back pain is coming from. It's probably your vertebrogenic endplate changes that are causing your back pain.' So that's been a big change in our algorithm. We'll see patients for the first time and see if we can get them in the portal and treated.”
Kiran V. Patel, MD
Director, Neurosurgical Pain, Lenox Hill Hospital, NY
“For the right patient with lower back pain, the Intracept procedure is life changing. Of all of the procedures that I perform, it has delivered the most dramatic results for my patients.”
Casey Muir, MD
Southwest Spine and Pain Center,
St George, UT
“This is an exciting new treatment option for a type chronic low back pain that we haven't had a solution. Intracept treats focal low back pain that occurs from degeneration of the intervertebral discs causing vertebrogenic back pain. This pain stays in the low back and generally gets worse with bending forward. If you have these back pain features Intracept may be the solution to your back pain.”
David Tran, MD
Axion Spine & Neurosurgery,
Alpharetta, GA
“Intracept is an innovative, safe, and highly effective treatment for chronic low back pain. Patients can see dramatic, lasting improvements from this minimally invasive procedure, with little post-procedure pain and quick recovery time.”
Carousel Video
Looking for proof?
Hear from the ones living it.
Kourtney’s Story
“My best friend said to me, I have not heard you talk about your back in so long.”
Kourtney’s Story
“My best friend said to me, I have not heard you talk about your back in so long.”
Kourtney’s Story
“My best friend said to me, I have not heard you talk about your back in so long.”
Kourtney’s Story
“My best friend said to me, I have not heard you talk about your back in so long.”
Kourtney’s Story
“My best friend said to me, I have not heard you talk about your back in so long.”
Video Grid
Kourtney’s Story
“My best friend said to me, I have not heard you talk about your back in so long.”
Kourtney’s Story
“My best friend said to me, I have not heard you talk about your back in so long.”
Kourtney’s Story
“My best friend said to me, I have not heard you talk about your back in so long.”
Kourtney’s Story
“My best friend said to me, I have not heard you talk about your back in so long.”
Story
Debbie’s Story
Multiple injections, multiple failed
approaches—nothing worked.
Nullam quis risus eget urna mollis ornare vel eu leo. Cras justo odio, dapibus ac facilisis in, egestas eget quam. Duis mollis, est non commodo luctus, nisi erat porttitor ligula, eget lacinia odio sem nec elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec ullamcorper nulla non metus auctor fringilla. Cras justo odio, dapibus ac facilisis in, egestas eget quam.
Duis mollis, est non commodo luctus, nisi erat porttitor ligula, eget lacinia odio sem nec elit. Donec sed odio dui. Curabitur blandit tempus porttitor. Nullam quis risus eget urna mollis ornare vel eu leo. Etiam porta sem malesuada magna mollis euismod. Curabitur blandit tempus porttitor.
Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Cras justo odio, dapibus ac facilisis in, egestas eget quam. Vivamus sagittis lacus vel augue laoreet rutrum faucibus dolor auctor. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Sed posuere consectetur est at lobortis.
Next Step forms
Access Instruments CTA
The Intracept® System:
Now with Next-Generation Access Instruments
